Summary
The Anesthetics for Battlefield Care (ABC) program seeks to develop safe, battlefield-ready anesthetics in order to reduce injury-associated trauma and improve combat casualty outcomes.
To achieve this goal, the program will seek to disentangle the poorly-understood neural and molecular mechanisms of anesthetics.
Program success will be gauged by the ability to design drugs that are much safer than current options, rendering them capable of unmonitored anesthesia for the warfighter.
